MedPath

Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia

Phase 3
Completed
Conditions
Leukemia
Interventions
Registration Number
NCT00281918
Lead Sponsor
Hoffmann-La Roche
Brief Summary

This randomized phase III trial is studying fludarabine, cyclophosphamide, and rituximab to see how well they work compared to fludarabine and cyclophosphamide in treating patients with B-cell chronic lymphocytic leukemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
817
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fludarabine+Cyclophosphamide+Rituximab (FCR)Rituximab-
Fludarabine+Cyclophosphamide+Rituximab (FCR)Cyclophosphamide-
Fludarabine+Cyclophosphamide+Rituximab (FCR)Fludarabine Phosphate-
Fludarabine+Cyclophosphamide (FC)Cyclophosphamide-
Fludarabine+Cyclophosphamide (FC)Fludarabine Phosphate-
Primary Outcome Measures
NameTimeMethod
Progression-free Survival (PFS)Median observation time at time of analysis was approximately 21 months

Progression-free survival (PFS) was defined as the time between randomization and the date of first documented disease progression, relapse or death by any cause, whichever came first.

Final Analysis: Time to Progression-free Survival EventMedian observation time was approximately 66.4 months

Progression-free survival was defined as the time between randomization and the date of first documented disease progression, relapse or death by any cause, whichever came first.

Secondary Outcome Measures
NameTimeMethod
Event-free Survival (EFS)Median observation time at time of analysis was approximately 21 months

Event-free survival (EFS) was defined as the time between randomization and the date of disease progression, relapse, start of new CLL treatment or death by any cause.

Overall Survival (OS)Median observation time at time of analysis was approximately 21 months

Overall survival (OS) was defined as the time between randomization and the date of death due to any cause. Median OS was not reached.

Disease-free Survival (DFS) of Patients With Confirmed Complete Response (CR).Median observation time at time of analysis was approximately 21 months

CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. DFS was calculated from time of CR to relapse or death. Median DFS was not reached.

Final Analysis: Time to Overall Survival EventMedian observation time was approximately 66.4 months

Overall survival (OS) was defined as the time between randomization and the date of death due to any cause.

Final Analysis: Time to Event-free Survival EventMedian observation time was approximately 66.4 months

Event-free survival was defined as the time between randomization and the date of disease progression, relapse, start of new Chronic Lymphocytic Leukemia treatment or death by any cause.

Final Analysis: Time to Disease-free Survival (DFS) Event in Participants With Complete Response (CR)Median observation time was approximately 66.4 months

CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. DFS was calculated from time of CR to relapse or death

Final Analysis: Duration of ResponseMedian observation time was approximately 66.4 months

Duration of response was defined as the time from the first documented Complete Response, Partial Response to disease progression or death by any cause.

Final Analysis: Percentage of Participants With Complete Response (CR) and Partial ResponseMedian observation time was approximately 66.4 months

CR is defined by at least 8 weeks of: 1)Absence of lymphadenopathy 2)No hepatomegaly or splenomegaly 3)Absence of B-symptoms 4)Normal blood count 5)Bone marrow aspirate and biopsy 8 weeks after the clinical and laboratory results demonstrated that a CR was achieved. A marrow sample had to be normocellular for age with less than 30% lymphocytes. Lymphoid nodules had to be absent. If marrow was hypocellular,a repeat biopsy was taken 4 weeks later and samples were re-reviewed in conjunction with the prior pathology. Partial response is defined as a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.

Final Analysis: Time to New Treatment for Chronic Lymphocytic Leukemia(CLL)Median observation time was approximately 66.4 months

The time from randomization to the start of a new treatment.

Trial Locations

Locations (160)

Praxis Fur Hamatologie und Onkologie Ahaus

🇩🇪

Ahaus, Germany

Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg

🇩🇪

Augsburg, Germany

Onkologische Schwerpunktpraxis Bielefeld

🇩🇪

Bielefeld, Germany

DIAKO Ev. Diakonie Krankenhaus gGmbH

🇩🇪

Bremen, Germany

Klinikum Lippe - Lemgo

🇩🇪

Lemgo, Germany

III Medizinische Klinik Mannheim

🇩🇪

Mannheim, Germany

Hamatologie/Onkologie Praxisgemeinschaft - Muenchen

🇩🇪

Muenchen, Germany

University of Muenster

🇩🇪

Muenster, Germany

Onkologische Gemeinschaftspraxis - Trier

🇩🇪

Trier, Germany

Hospital General Universitario Morales Meseguer

🇪🇸

Murcia, Spain

Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie

🇩🇪

Ansbach, Germany

Internistische Gemeinschaftspraxis - Berlin

🇩🇪

Berlin, Germany

Universitaetsklinikum Duesseldorf

🇩🇪

Duesseldorf, Germany

Florence-Nightingale-Krankenhause, Deaconess Kaiserswerth

🇩🇪

Dusseldorf, Germany

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin

🇩🇪

Berlin, Germany

Marienhospital Bottrop gGmbH

🇩🇪

Bottrop, Germany

Onkologische Schwerpunktpraxis at Facharzt fuer Innere Medizin

🇩🇪

Coesfeld, Germany

Medizinische Universitaetsklinik I at the University of Cologne

🇩🇪

Cologne, Germany

Onkologische Schwerpunkt Praxis

🇩🇪

Erlangen, Germany

Krankenhaus Benrath

🇩🇪

Dusseldorf, Germany

St. Antonius Hospital

🇩🇪

Eschweiler, Germany

Evangelisches Krankenhaus Essen Werden

🇩🇪

Essen, Germany

St. Georg Klinikum Eisenach GmbH

🇩🇪

Eisenach, Germany

Internistiche Praxis

🇩🇪

Erfurt, Germany

Universitaetsklinikum Essen

🇩🇪

Essen, Germany

Staedtische Kliniken Esslingen

🇩🇪

Esslingen, Germany

Gemeinschaftspraxis - Freiburg

🇩🇪

Freiburg, Germany

Internistische Praxis - Gerlingen

🇩🇪

Gerlingen, Germany

St. Marien-Hospital Hamm - Klinik Knappenstrasse

🇩🇪

Hamm, Germany

Evangelische Krankenhaus Hamm

🇩🇪

Hamm, Germany

St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH

🇩🇪

Hagen, Germany

Internistische Praxis - Halle

🇩🇪

Halle, Germany

Marienhospital at Ruhr University Bochum

🇩🇪

Herne, Germany

Privatklinik Dr. R. Schindlbeck GmbH & Co. KG

🇩🇪

Herrsching, Germany

Internistische Gemeinschaftspraxis - Kassel

🇩🇪

Kassel, Germany

University Hospital Schleswig-Holstein - Kiel Campus

🇩🇪

Kiel, Germany

Universitaetsklinikum Halle

🇩🇪

Halle, Germany

Asklepios Klinik St. Georg

🇩🇪

Hamburg, Germany

University Medical Center Hamburg - Eppendorf

🇩🇪

Hamburg, Germany

Stiftungsklinikum Mittelrhein - Gesundheitszentrum Evangelisches Stift Sankt Martin Koblenz gGmbH

🇩🇪

Koblez, Germany

Internistische Gemeinschaftspraxis - Magdeburg

🇩🇪

Magdeburg, Germany

Krankenhaus Maria Hilf GmbH

🇩🇪

Moenchengladbach, Germany

Universitatsklinik Mainz

🇩🇪

Mainz, Germany

Praxis fuer Haematologie und Interne Onkologie

🇩🇪

Norderstedt, Germany

Haematologisch - Onkologische Gemeinschaftspraxis

🇩🇪

Muenster, Germany

Klinikum der Universitaet Muenchen - Grosshadern Campus

🇩🇪

Munich, Germany

Westmead Institute for Cancer Research at Westmead Hospital

🇦🇺

Westmead - Wentworthville, New South Wales, Australia

Gosford Hospital

🇦🇺

Gosford, New South Wales, Australia

Frankston Hospital

🇦🇺

Frankston, Victoria, Australia

Royal Brisbane and Women's Hospital

🇦🇺

Brisbane, Queensland, Australia

Peter MacCallum Cancer Centre

🇦🇺

East Melbourne, Victoria, Australia

Rudolfinerhaus

🇦🇹

Vienna, Austria

Hanuschkrankenhaus

🇦🇹

Vienna, Austria

Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik

🇦🇹

Wien, Austria

AZ Sint-Jan

🇧🇪

Brugge, Belgium

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Institut Jules Bordet

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

U.Z. Gasthuisberg

🇧🇪

Leuven, Belgium

Masaryk University Hospital

🇨🇿

Brno, Czech Republic

University Hospital - Olomouc

🇨🇿

Olomouc, Czech Republic

Clinique Universitaire De Mont-Godinne

🇧🇪

Mont-Godinne Yvoir, Belgium

Fakultni Nemocnice Hradec Kralove

🇨🇿

Hradec Kralove, Czech Republic

University Hospital in Pilsen - Lochotin

🇨🇿

Pilsen-Lochotin, Czech Republic

Vejle Sygehus

🇩🇰

Vejle, Denmark

Copenhagen County Herlev University Hospital

🇩🇰

Copenhagen, Denmark

Centre Leon Berard

🇫🇷

Lyon, France

Hopital Andre Mignot

🇫🇷

Le Chesnay, France

Centre Hospitalier Universitaire de Rennes

🇫🇷

Rennes, France

Institut de Cancerologie de la Loire

🇫🇷

Saint Priest en Jarez, France

Internistische Praxis - Dusseldorf

🇩🇪

Dusseldorf, Germany

Klinikum Frankfurt (Oder) GmbH

🇩🇪

Frankfurt (Oder), Germany

Klinikum Garmisch - Partenkirchen GmbH

🇩🇪

Garmisch-Partenkirchen, Germany

Universitaetsklinikum des Saarlandes

🇩🇪

Homburg, Germany

Krankenhaus Siloah - Medizinische Klinik II

🇩🇪

Hannover, Germany

Universitatsklinikum Heidelberg

🇩🇪

Heidelberg, Germany

St. Vincentius-Kliniken

🇩🇪

Karlsruhe, Germany

Klinikum Kempten Oberallgaeu

🇩🇪

Kempten, Germany

Clinic for Bone Marrow Transplantation and Hematology and Oncology

🇩🇪

Idar-Oberstein, Germany

Gemeinschaftspraxis Innere Medizin

🇩🇪

Jena, Germany

Staedtisches Klinikum Karlsruhe gGmbH

🇩🇪

Karlsruhe, Germany

Internistische Praxis - Kiel

🇩🇪

Kiel, Germany

Praxis fuer Haematologie und Onkologie

🇩🇪

Koblenz, Germany

Internistische Onkologische Praxis - Kronach

🇩🇪

Kronach, Germany

Klinikum Landshut

🇩🇪

Landshut, Germany

Gemeinschaftspraxis - Ludwigshafen

🇩🇪

Ludwigshafen, Germany

Sana Kliniken Luebeck

🇩🇪

Luebeck, Germany

Staedtisches Klinikum Magdeburg - Altstadt

🇩🇪

Magdeburg, Germany

Onkologische Schwerpunktpraxis Dr. Schmidt

🇩🇪

Neunkirchen, Germany

Klinikum Nuernberg - Klinikum Nord

🇩🇪

Nuernberg, Germany

Haematologische Schwerpunktpraxis

🇩🇪

Munich, Germany

Gemeinschaftspraxis - Oberhausen

🇩🇪

Oberhausen, Germany

Internistische Gemeinschaftspraxis - Oldenburg

🇩🇪

Oldenburg, Germany

Internistische Gemeinschaftspraxis - Offenbach

🇩🇪

Offenbach, Germany

Klinikum Ernst Von Bergmann

🇩🇪

Potsdam, Germany

St. Marien - Krankenhaus Siegen GMBH

🇩🇪

Siegen, Germany

Marienhospital Stuttgart

🇩🇪

Stuttgart, Germany

KKH Torgau

🇩🇪

Torgau, Germany

Universitaetsklinikum Tuebingen

🇩🇪

Tuebingen, Germany

Praxis Fuer Internistische Haematologie / Onkologie

🇩🇪

Troisdorf, Germany

Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm

🇩🇪

Ulm, Germany

Praxis fur Innere Medizin - Wanzleben

🇩🇪

Wanzleben, Germany

Schwerpunktpraxis Hamatologie/Onkologie - Wesel

🇩🇪

Wesel, Germany

Dr. Horst-Schmidt-Kliniken

🇩🇪

Wiesbaden, Germany

Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg

🇩🇪

Wuerzburg, Germany

Soroka University Medical Center

🇮🇱

Beer-Sheva, Israel

Kliniken St. Antonius

🇩🇪

Wuppertal 2, Germany

Hamatologisch - Onkologische Praxis Wurzburg

🇩🇪

Wurzburg, Germany

BNAI Zion Medical Center

🇮🇱

Haifa, Israel

Kaplan Hospital

🇮🇱

Rehovot, Israel

Perugia Regional Cancer Center

🇮🇹

Perugia, Italy

Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore

🇮🇹

Rome, Italy

Auckland City Hospital

🇳🇿

Auckland, New Zealand

Hospital Virgen Del La Salud

🇪🇸

Toledo, Spain

Hopital Louis Pasteur

🇫🇷

Colmar, France

Internistische Praxis - Bayreuth

🇩🇪

Bayreuth, Germany

Krankenhaus Burglengenfeld

🇩🇪

Burglengenfeld, Germany

Onkologische Schwerpunktpraxis

🇩🇪

Cottbus, Germany

Helios Klinikum Erfurt

🇩🇪

Erfurt, Germany

Staedtische Kliniken Frankfurt am Main - Hoechst

🇩🇪

Frankfurt, Germany

Universitaetsklinikum Goettingen

🇩🇪

Goettingen, Germany

Princess Alexandra Hospital

🇦🇺

Brisbane, Queensland, Australia

Humaine - Clinic

🇩🇪

Bad Saarow, Germany

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes

🇫🇷

Marseille, France

Krankenhaus Bietigheim

🇩🇪

Bietigheim, Germany

Praxis Fuer Haematologie Internistische Onkologie

🇩🇪

Cologne, Germany

Onkologische Gemeinschaftspraxis - Dresden

🇩🇪

Dresden, Germany

Internistische Gemeinschaftspraxis - Forchheim

🇩🇪

Forchheim, Germany

Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie

🇩🇪

Giessen, Germany

First Medical Clinic of Charles University Hospital

🇨🇿

Prague, Czech Republic

Klinikum Augsburg

🇩🇪

Augsburg, Germany

Augusta-Kranken-Anstalt gGmbH

🇩🇪

Bochum, Germany

Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet

🇩🇪

Greifswald, Germany

Onkologische Schwerpunktpraxis - Leer

🇩🇪

Leer, Germany

Klinikum "St. Georg" Leipzig

🇩🇪

Leipzig, Germany

Caritasklinik St. Theresia

🇩🇪

Saarbrucken, Germany

Nordwestkrankenhaus Sanderbusch

🇩🇪

Sanderbusch, Germany

Riverview Cancer Care Medical Associates, PC

🇮🇱

Kfar Saba, Israel

Fondazione Centro San Raffaele Del Monte Tabor

🇮🇹

Milano, Italy

Ospedale Sant' Eugenio

🇮🇹

Rome, Italy

Internistische Praxis - Loerrach

🇩🇪

Loerrach, Germany

Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg

🇩🇪

Magdeburg, Germany

Staedtisches Krankenhaus Muenchen - Harlaching

🇩🇪

Munich, Germany

Klinikum Rechts Der Isar - Technische Universitaet Muenchen

🇩🇪

Munich, Germany

Klinikum Oldenburg

🇩🇪

Oldenburg, Germany

Klinik fuer Onkologie - Katharinenhospital Stuttgart

🇩🇪

Stuttgart, Germany

Hadassah University Hospital

🇮🇱

Jerusalem, Israel

Palmerston North Hospital

🇳🇿

Palmerston North, New Zealand

Asklepios Klinik Pasewalk

🇩🇪

Pasewalk, Germany

Municipal Hospital Complex

🇩🇪

Villingen-Schwenningen, Germany

Internistische Gemeinschaftspraxis - Stuttgart

🇩🇪

Stuttgart, Germany

Rambam Medical Center

🇮🇱

Haifa, Israel

Ospedale Oncologico A. Businco

🇮🇹

Cagliari, Italy

Elisabeth Krankenhaus

🇩🇪

Recklinghausen, Germany

Krankenhaus Barmherzige Brueder Regensburg

🇩🇪

Regensburg, Germany

Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock

🇩🇪

Rostock, Germany

Haematologische Praxis

🇩🇪

Weiden, Germany

Diakonie Klinikum Stuttgart

🇩🇪

Stuttgart, Germany

Krankenanstalt Mutterhaus der Borromaerinnen

🇩🇪

Trier, Germany

Canterbury Health Laboratories

🇳🇿

Christchurch, New Zealand

© Copyright 2025. All Rights Reserved by MedPath